Asymptomatic bacteriuria in pregnancy
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2023
DOI: 10.1111/ajo.13693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2023. Verfasst von Madeleine Sheppard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, Reproduction and Perinatal Centre, The University of Sydney, New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Bacteriuria, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Philanthropic funding in memory of Kiera Brady Liston via kierascontribution.com, RANZCOG Research Foundation.
Abstract (Originalsprache)
Background
Asymptomatic bacteriuria (ASB) is associated with adverse maternal and neonatal outcomes and is routinely screened for and treated in the first trimester. Prevalence of ASB in the second and third trimesters of pregnancy is unknown.
Aims
The aim is to determine the prevalence of ASB in the second and third trimesters of pregnancy.
Methods
Prospective cohort study of 150 pregnant women. Mid‐stream urine samples were tested for ASB in the second (24–28 +6 ) and third (32–36 +6 ) trimesters. Women were assigned to one of two groups: (i) ASB in any trimester of pregnancy and (ii) no evidence of ASB in pregnancy. Maternal and neonatal outcomes were compared between groups.
Results
Among 143 women included in the study, the rate of ASB was 4.9% (2.1, 2.1 and 3.2% in the first, second and third trimesters, respectively). Of those with ASB, 14% had it in every trimester, whereas 43% had it on two or more samples. Of those with ASB in pregnancy, 43% were detected for the first time in the third trimester. Rates of maternal and neonatal outcomes were not statistically significantly different between the two groups. No women with ASB were induced for chorioamnionitis or growth restriction.
Conclusion
The rate of ASB was highest in the third trimester of pregnancy, with rates of 2.1, 2.1 and 3.2% in the first, second and third trimesters, respectively. This study was underpowered to assess maternal and fetal outcomes. Although numbers were small, the absence of ASB in the first trimester was a poor predictor of ASB in the third trimester.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health, Reproduction and Perinatal Centre, The University of Sydney, New South Wales, Sydney, Australia.
- Kolling Institute, Northern Sydney Local Health District, New South Wales, St Leonards, Australia.
- Department of Obstetrics and Gynaecology, Royal North Shore Hospital, New South Wales, St Leonards, Australia.
- Clinical Excellence Commission, New South Wales Ministry of Health, New South Wales, Sydney, Australia.
ORCID-Profile: Madeleine Sheppard, Ibinabo Ibiebele, Tanya Nippita
Förderung
- Philanthropic funding in memory of Kiera Brady Liston via kierascontribution.com
- RANZCOG Research Foundation
Zitieren
APA
Sheppard, M., Ibiebele, I., Nippita, T., & Morris, J. (2023). Asymptomatic bacteriuria in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13693
Vancouver
Sheppard M, Ibiebele I, Nippita T, Morris J. Asymptomatic bacteriuria in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2023. doi:10.1111/ajo.13693
BibTeX
@article{Sheppard2023,
author = {Sheppard, Madeleine and Ibiebele, Ibinabo and Nippita, Tanya and Morris, Jonathan},
title = {Asymptomatic bacteriuria in pregnancy},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2023},
doi = {10.1111/ajo.13693}
}
EUVIMED